1. Home
  2. ELTX vs FEAM Comparison

ELTX vs FEAM Comparison

Compare ELTX & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • FEAM
  • Stock Information
  • Founded
  • ELTX 2011
  • FEAM 2016
  • Country
  • ELTX United States
  • FEAM United States
  • Employees
  • ELTX N/A
  • FEAM N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • ELTX Health Care
  • FEAM Industrials
  • Exchange
  • ELTX Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • ELTX 121.7M
  • FEAM 70.5M
  • IPO Year
  • ELTX N/A
  • FEAM N/A
  • Fundamental
  • Price
  • ELTX $8.09
  • FEAM $3.61
  • Analyst Decision
  • ELTX Strong Buy
  • FEAM Strong Buy
  • Analyst Count
  • ELTX 2
  • FEAM 2
  • Target Price
  • ELTX $9.50
  • FEAM $121.00
  • AVG Volume (30 Days)
  • ELTX 48.3K
  • FEAM 15.1K
  • Earning Date
  • ELTX 08-12-2025
  • FEAM 09-03-2025
  • Dividend Yield
  • ELTX N/A
  • FEAM N/A
  • EPS Growth
  • ELTX N/A
  • FEAM N/A
  • EPS
  • ELTX N/A
  • FEAM N/A
  • Revenue
  • ELTX N/A
  • FEAM N/A
  • Revenue This Year
  • ELTX N/A
  • FEAM N/A
  • Revenue Next Year
  • ELTX N/A
  • FEAM N/A
  • P/E Ratio
  • ELTX N/A
  • FEAM N/A
  • Revenue Growth
  • ELTX N/A
  • FEAM N/A
  • 52 Week Low
  • ELTX $3.70
  • FEAM $2.82
  • 52 Week High
  • ELTX $9.99
  • FEAM $27.14
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 62.14
  • FEAM 44.88
  • Support Level
  • ELTX $7.76
  • FEAM $3.42
  • Resistance Level
  • ELTX $8.94
  • FEAM $3.75
  • Average True Range (ATR)
  • ELTX 0.37
  • FEAM 0.25
  • MACD
  • ELTX -0.03
  • FEAM 0.02
  • Stochastic Oscillator
  • ELTX 51.09
  • FEAM 45.16

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: